Close

Anti-NBN DNA-encoded mAb (DMAb), pVAX1 (DMAb-1181-WJ)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-NBN DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • NBN
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 4683
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-0860-WJ 1D7 Mouse IgG1 The complete coding region of the human p95/NBS1 expressed in E. coli.
DMAb-342-YC 3E4 Mouse Human IgG2a, κ Partial recombinant corresponding to aa645-754 from human NBN (NP_002476) with GST tag. MW of the GST tag alone is 26kD
DMAb-033-YC 8E6 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-1187-WJ 8E7 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E. coli
DMAb-0818-LY 2E9 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 461-754 of human NBN (NP_002476) produced in E.coli
DMAb-659-YC 2E10 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-1190-WJ 5E11 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-1191-WJ 6E11 Mouse Human IgG2a Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E. coli
DMAb-607-YC 1C3 Mouse IgG1 The complete coding region of the human p95/NBS1 expressed in E. coli
DMAb-1323-LY 1C9 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 461-754 of human NBN (NP_002476) produced in E.coli
DMAb-370-YC 1F11 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 461-754 of human NBN (NP_002476) produced in E.coli
DMAb-0015-WJ 1G1 Mouse Human IgG2a Human recombinant protein fragment corresponding to amino acids 461-754 of human NBN (NP_002476) produced in E.coli
DMAb-602-YC 1G10 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 461-754 of human NBN (NP_002476) produced in E.coli
DMAb-497-YC 1G8 Mouse Human IgG2b Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E.coli
DMAb-510-YC 2C7 Mouse IgG2a, κ NBN (NP_002476, 645aa-754aa) partial recombinant protein with GST tag. MW of the GST tag alone is 26kD
DMAb-1201-WJ 2F5 Mouse Human IgG2b Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-0156-YJ 2G4 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-1203-WJ 2T17 Mouse Human IgG2a Recognizes phosphorylated Nibrin/nbs1 (Ser343), Mr ~100kD, which exhibits slower mobility in SDS-PAGE relative to unphosphorylated Nibrin
DMAb-0958-LY 3A2 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 461-754 of human NBN (NP_002476) produced in E.coli
DMAb-3597CQ 3A4 Mouse Human IgG2a Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-M137-YC 3A9 Mouse Human IgG2a Human recombinant protein fragment corresponding to amino acids 461-754 of human NBN (NP_002476) produced in E.coli
DMAb-0509-FY 3C12 Mouse Human IgG2a Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-0087-YJ 3G3 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E.coli
DMAb-1210-WJ 3J15 Mouse Human IgG GST fusion protein corresponding to residues 420-774 of human Nibrin
DMAb-1211-WJ 4H9 Mouse Human IgG1
DMAb-1212-WJ 5A6 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 461-754 of human NBN (NP_002476) produced in E.coli
DMAb-1111-CQ 6A3 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-1122-WJ 6D10 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-1215-WJ 6H7 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E.coli
DMAb-401-YC 7D5 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-1217-WJ 7E4C2 Mouse Human IgG2a Purified recombinant fragment of human NBN (AA: 467-615) expressed in E. Coli
DMAb-0655-WJ 9H2 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476) produced in E.coli
DMAb-0739-WJ B-5 Mouse Human
DMAb-1220-WJ E11 Mouse Human IgG2a Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E.coli
DMAb-1221-WJ E7 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E.coli
DMAb-1222-WJ G3 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E.coli
DMAb-169-YC G8 Mouse Human IgG2b Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E.coli
DMAb-894-YC H7 Mouse Human IgG1 Human recombinant protein fragment corresponding to amino acids 183-460 of human NBN (NP_002476)produced in E.coli
DMAb-1227-WJ Y112 Rabbit IgG A synthetic peptide corresponding to residues near C-terminus of human Nibrin was used as immunogen

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-NBN DNA-encoded mAb (DMAb), pVAX1 (DMAb-1181-WJ). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.